Biomarkers for CNS injury in COVID-19 and relationship to neurological symptoms and disease severity


  • Most patients with coronavirus disease 2019 (COVID-19) had a negative standard cerebrospinal fluid (CSF) workup, but markers or neuronal injury were increased.

Why this matters

    Few studies have investigated CSF in patients with COVID-19; understanding COVID-19 relates to CSF analyses and neuronal injury markers may aid in improving treatment outcomes.